Item Type | Name |
Academic Article
|
Sentinel lymph node biopsy for conjunctival melanoma.
|
Academic Article
|
p53 codon 72 Arg homozygotes are associated with an increased risk of cutaneous melanoma.
|
Academic Article
|
Elective radiotherapy provides regional control for patients with cutaneous melanoma of the head and neck.
|
Academic Article
|
Adjuvant irradiation for cervical lymph node metastases from melanoma.
|
Academic Article
|
Activation of stat3 in human melanoma promotes brain metastasis.
|
Academic Article
|
Galectin-3 expression is associated with tumor progression and pattern of sun exposure in melanoma.
|
Academic Article
|
Repair of UV light-induced DNA damage and risk of cutaneous malignant melanoma.
|
Academic Article
|
Feasibility of preoperative lymphoscintigraphy for identification of sentinel lymph nodes in patients with conjunctival and periocular skin malignancies.
|
Academic Article
|
Microscopic tumor burden in sentinel lymph nodes predicts synchronous nonsentinel lymph node involvement in patients with melanoma.
|
Academic Article
|
Combined-modality therapy for patients with regional nodal metastases from melanoma.
|
Academic Article
|
In vitro sensitivity to ultraviolet B light and skin cancer risk: a case-control analysis.
|
Academic Article
|
Adjuvant high-dose interferon for cutaneous melanoma is most beneficial for patients with early stage III disease.
|
Academic Article
|
Phase II trial of imatinib mesylate in patients with metastatic melanoma.
|
Academic Article
|
Immunohistochemical detection of lymphovascular invasion with D2-40 in melanoma correlates with sentinel lymph node status, metastasis and survival.
|
Academic Article
|
CpG island methylation profiling in human melanoma cell lines.
|
Academic Article
|
DNA repair gene XRCC3 241Met variant is not associated with risk of cutaneous malignant melanoma.
|
Academic Article
|
Melanoma metastatic to cervical lymph nodes: Can radiotherapy replace formal dissection after local excision of nodal disease?
|
Academic Article
|
The expression of p-STAT3 in stage IV melanoma: risk of CNS metastasis and survival.
|
Concept
|
Melanoma
|
Concept
|
Melanoma, Experimental
|
Academic Article
|
Hepatic resection for metastatic melanoma: distinct patterns of recurrence and prognosis for ocular versus cutaneous disease.
|
Academic Article
|
A new American Joint Committee on Cancer staging system for cutaneous melanoma.
|
Academic Article
|
Clinical classification and staging.
|
Academic Article
|
Significance of plasma cytokine levels in melanoma patients with histologically negative sentinel lymph nodes.
|
Academic Article
|
Dominant-negative transcription factor AP-2 augments SB-2 melanoma tumor growth in vivo.
|
Academic Article
|
Implications of lymphatic drainage to unusual sentinel lymph node sites in patients with primary cutaneous melanoma.
|
Academic Article
|
New TNM melanoma staging system: linking biology and natural history to clinical outcomes.
|
Academic Article
|
Biochemotherapy in patients with metastatic anorectal mucosal melanoma.
|
Academic Article
|
A critical assessment of adjuvant radiotherapy for inguinal lymph node metastases from melanoma.
|
Academic Article
|
Metastatic melanoma to lymph nodes in patients with unknown primary sites.
|
Academic Article
|
Melanoma patients with positive sentinel nodes who did not undergo completion lymphadenectomy: a multi-institutional study.
|
Academic Article
|
Ethnic differences among patients with cutaneous melanoma.
|
Academic Article
|
Clinical relevance of melanoma micrometastases in sentinel nodes: too early to tell.
|
Academic Article
|
Prospective assessment of the reliability, validity, and sensitivity to change of the Functional Assessment of Cancer Therapy-Melanoma questionnaire.
|
Academic Article
|
Constitutive expression of the alpha4 integrin correlates with tumorigenicity and lymph node metastasis of the B16 murine melanoma.
|
Academic Article
|
Clinical correlates of NRAS and BRAF mutations in primary human melanoma.
|
Academic Article
|
Prognostic significance of mitotic rate in localized primary cutaneous melanoma: an analysis of patients in the multi-institutional American Joint Committee on Cancer melanoma staging database.
|
Academic Article
|
Evidence-based treatment of early-stage melanoma.
|
Academic Article
|
Genome-wide association study identifies novel loci predisposing to cutaneous melanoma.
|
Academic Article
|
A lupus-like reaction to subcutaneous interferon-a at injection sites.
|
Academic Article
|
Specific lymphocyte subsets predict response to adoptive cell therapy using expanded autologous tumor-infiltrating lymphocytes in metastatic melanoma patients.
|
Academic Article
|
Variants in melanocortin 1 receptor gene contribute to risk of melanoma--a direct sequencing analysis in a Texas population.
|
Academic Article
|
Clinical activity and safety of combination therapy with temsirolimus and bevacizumab for advanced melanoma: a phase II trial (CTEP 7190/Mel47).
|
Academic Article
|
Is surveillance imaging effective for detecting surgically treatable recurrences in patients with melanoma? A comparative analysis of stage-specific surveillance strategies.
|
Academic Article
|
Semiconductor-based DNA sequencing of histone modification states.
|
Academic Article
|
Tissue resources for clinical use and marker studies in melanoma.
|
Academic Article
|
Age as a predictor of sentinel node metastasis among patients with localized melanoma: an inverse correlation of melanoma mortality and incidence of sentinel node metastasis among young and old patients.
|
Academic Article
|
Improved sentinel lymph node localization in patients with primary melanoma with the use of radiolabeled colloid.
|
Academic Article
|
Classification and staging of melanoma.
|
Academic Article
|
Role for lymphatic mapping and sentinel lymph node biopsy in patients with thick (> or = 4 mm) primary melanoma.
|
Academic Article
|
Sphincter-sparing local excision and adjuvant radiation for anal-rectal melanoma.
|
Academic Article
|
Surgical clinical trials in melanoma.
|
Academic Article
|
The new melanoma staging system.
|
Academic Article
|
Epidermal hyperplasia overlying human melanoma correlates with tumour depth and angiogenesis.
|
Academic Article
|
Lymphatic mapping in the molecular era.
|
Academic Article
|
The new staging system for cutaneous melanoma in the era of lymphatic mapping.
|
Academic Article
|
Predictors and natural history of in-transit melanoma after sentinel lymphadenectomy.
|
Academic Article
|
Intraoperative frozen-section evaluation can reduce accuracy of pathologic assessment of sentinel nodes in melanoma patients.
|
Academic Article
|
Genetic variants of the vitamin D receptor gene alter risk of cutaneous melanoma.
|
Academic Article
|
Accuracy of lymphatic mapping and sentinel lymph node biopsy after previous wide local excision in patients with primary melanoma.
|
Academic Article
|
Segmental neurofibromatosis in association with a large congenital nevus and malignant melanoma.
|
Academic Article
|
Cost effectiveness of adjuvant interferon in node-positive melanoma.
|
Academic Article
|
Pelvic lymph node dissection is beneficial in subsets of patients with node-positive melanoma.
|
Academic Article
|
Melanoma adrenal metastasis: natural history and surgical management.
|
Academic Article
|
Impact of sentinel lymphadenectomy on survival in a murine model of melanoma.
|
Academic Article
|
Genetic variants and haplotypes of the caspase-8 and caspase-10 genes contribute to susceptibility to cutaneous melanoma.
|
Academic Article
|
Fibrin sealant does not decrease seroma output or time to drain removal following inguino-femoral lymph node dissection in melanoma patients: a randomized controlled trial (NCT00506311).
|
Academic Article
|
Radiation therapy field extent for adjuvant treatment of axillary metastases from malignant melanoma.
|
Academic Article
|
A subset of host B lymphocytes controls melanoma metastasis through a melanoma cell adhesion molecule/MUC18-dependent interaction: evidence from mice and humans.
|
Academic Article
|
Lymph node ratio predicts disease-specific survival in melanoma patients.
|
Academic Article
|
Sentinel node biopsy and standard of care for melanoma.
|
Academic Article
|
A randomized phase III trial of biochemotherapy versus interferon-alpha-2b for adjuvant therapy in patients at high risk for melanoma recurrence.
|
Academic Article
|
Prospective assessment of postoperative complications and associated costs following inguinal lymph node dissection (ILND) in melanoma patients.
|
Academic Article
|
Mutational and functional analysis reveals ADAMTS18 metalloproteinase as a novel driver in melanoma.
|
Academic Article
|
Multimethod imaging, staging, and spectrum of manifestations of metastatic melanoma.
|
Academic Article
|
Exome sequencing identifies GRIN2A as frequently mutated in melanoma.
|
Academic Article
|
Impact of clinical and pathologic features on tumor-infiltrating lymphocyte expansion from surgically excised melanoma metastases for adoptive T-cell therapy.
|
Academic Article
|
Mapping FACT-melanoma quality-of-life scores to EQ-5D health utility weights.
|
Academic Article
|
Sentinel lymph node biopsy in melanoma.
|
Academic Article
|
Future perspectives in melanoma research. Meeting report from the "Melanoma research: a bridge from Naples to the World. Napoli, December 5th-6th 2011".
|
Academic Article
|
Somatic mutations in MAP3K5 attenuate its proapoptotic function in melanoma through increased binding to thioredoxin.
|
Academic Article
|
Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma.
|
Academic Article
|
Loss of AP-2 results in up-regulation of MCAM/MUC18 and an increase in tumor growth and metastasis of human melanoma cells.
|
Academic Article
|
Surgical margins and prognostic factors in patients with thick (>4mm) primary melanoma.
|
Academic Article
|
Significance of multiple nodal basin drainage in truncal melanoma patients undergoing sentinel lymph node biopsy.
|
Academic Article
|
How many lymph nodes are enough during sentinel lymphadenectomy for primary melanoma?
|
Academic Article
|
Sentinel lymph node biopsy for melanoma: how many radioactive nodes should be removed?
|
Academic Article
|
Patterns of regional and distant metastasis in patients with conjunctival melanoma: experience at a cancer center over four decades.
|
Academic Article
|
Adjuvant irradiation for axillary metastases from malignant melanoma.
|
Academic Article
|
[Effects of vascular endothelial growth factor D on the signaling cascade of sentinel lymphatic endothelial cells from melanoma patients undergoing sentinel lymphadenectomy].
|
Academic Article
|
An evidence-based staging system for cutaneous melanoma.
|
Academic Article
|
Re: Selective lymphadenectomy in sentinel node-positive patients may increase the risk of local/in-transit recurrence in malignant melanoma, Thomas and Clark.
|
Academic Article
|
Population-based assessment of surgical treatment trends for patients with melanoma in the era of sentinel lymph node biopsy.
|
Academic Article
|
Automated quantitative analysis of activator protein-2alpha subcellular expression in melanoma tissue microarrays correlates with survival prediction.
|
Academic Article
|
Assessment of the role of sentinel lymph node biopsy for primary cutaneous desmoplastic melanoma.
|
Academic Article
|
Impact of sentinel node status and other risk factors on the clinical outcome of head and neck melanoma patients.
|
Academic Article
|
Genetic variants of the ADPRT, XRCC1 and APE1 genes and risk of cutaneous melanoma.
|
Academic Article
|
Utility of computed tomography and magnetic resonance imaging staging before completion lymphadenectomy in patients with sentinel lymph node-positive melanoma.
|
Academic Article
|
Polymorphisms in the DNA repair genes XPC, XPD, and XPG and risk of cutaneous melanoma: a case-control analysis.
|
Academic Article
|
Polymorphisms of the neuronal and inducible nitric oxide synthase genes and the risk of cutaneous melanoma: a case-control study.
|
Academic Article
|
Is sentinel-node biopsy superior to nodal observation in melanoma?
|
Academic Article
|
Polymorphisms of TP53 Arg72Pro, but not p73 G4C14>A4TA4 and p21 Ser31Arg, contribute to risk of cutaneous melanoma.
|
Academic Article
|
Human melanoma cytolysis by combined inhibition of mammalian target of rapamycin and vascular endothelial growth factor/vascular endothelial growth factor receptor-2.
|
Academic Article
|
A novel AKT3 mutation in melanoma tumours and cell lines.
|
Academic Article
|
Role of sentinel lymph node biopsy in patients with thin melanoma.
|
Academic Article
|
Factors associated with false-negative sentinel lymph node biopsy in melanoma patients.
|
Academic Article
|
Conditional survival estimates improve over time for patients with advanced melanoma: results from a population-based analysis.
|
Academic Article
|
2010 TNM staging system for cutaneous melanoma...and beyond.
|
Academic Article
|
Conditional survival estimates improve over 5 years for melanoma survivors with node-positive disease.
|
Academic Article
|
Predicting survival outcome of localized melanoma: an electronic prediction tool based on the AJCC Melanoma Database.
|
Academic Article
|
Contemporary diagnostic imaging modalities for the staging and surveillance of melanoma patients: a meta-analysis.
|
Academic Article
|
Preface. Melanoma.
|
Academic Article
|
Targeted therapy for melanoma: a primer.
|
Academic Article
|
Sentinel-lymph-node biopsy for cutaneous melanoma.
|
Academic Article
|
Update on the melanoma staging system: the importance of sentinel node staging and primary tumor mitotic rate.
|
Academic Article
|
Exon capture analysis of G protein-coupled receptors identifies activating mutations in GRM3 in melanoma.
|
Academic Article
|
Influence of single nucleotide polymorphisms in the MMP1 promoter region on cutaneous melanoma progression.
|
Academic Article
|
A novel and accurate computer model of melanoma prognosis for patients staged by sentinel lymph node biopsy: comparison with the American Joint Committee on Cancer model.
|
Academic Article
|
A landscape of driver mutations in melanoma.
|
Academic Article
|
Variability in melanoma post-treatment surveillance practices by country and physician specialty: a systematic review.
|
Academic Article
|
Polymorphisms of nucleotide excision repair genes predict melanoma survival.
|
Academic Article
|
Sentinel lymph node biopsy for melanoma: a critical update for dermatologists after two decades of experience.
|
Academic Article
|
Prospective assessment of lymphedema incidence and lymphedema-associated symptoms following lymph node surgery for melanoma.
|
Academic Article
|
Age as a prognostic factor in patients with localized melanoma and regional metastases.
|
Academic Article
|
Clinical characteristics and outcomes with specific BRAF and NRAS mutations in patients with metastatic melanoma.
|
Academic Article
|
Randomized controlled trial of a sun protection intervention for children of melanoma survivors.
|
Academic Article
|
Impact of the 2009 (7th edition) AJCC melanoma staging system in the classification of thin cutaneous melanomas.
|
Academic Article
|
Expression of interleukin-8 by human melanoma cells up-regulates MMP-2 activity and increases tumor growth and metastasis.
|
Academic Article
|
Regional nodal basin control is not compromised by previous sentinel lymph node biopsy in patients with melanoma.
|
Academic Article
|
Gene expression profiling of human cutaneous melanoma: are we there yet?
|
Academic Article
|
The risk of in-transit melanoma metastasis depends on tumor biology and not the surgical approach to regional lymph nodes.
|
Academic Article
|
Polymorphisms of the FAS and FAS ligand genes associated with risk of cutaneous malignant melanoma.
|
Academic Article
|
Acne vulgaris: false-positive finding on integrated 18F-FDG PET/CT in a patient with melanoma.
|
Academic Article
|
Quantitative analysis of melanocytic tissue array reveals inverse correlation between activator protein-2alpha and protease-activated receptor-1 expression during melanoma progression.
|
Academic Article
|
Imaging studies in patients with melanoma.
|
Academic Article
|
Haplotype and genotypes of the VDR gene and cutaneous melanoma risk in non-Hispanic whites in Texas: a case-control study.
|
Academic Article
|
How should we view the results of the Multicenter Selective Lymphadenectomy Trial-1 (MSLT-1)?
|
Academic Article
|
Final version of 2009 AJCC melanoma staging and classification.
|
Academic Article
|
Promoter polymorphisms in matrix metallopeptidase 1 and risk of cutaneous melanoma.
|
Academic Article
|
Staging and prognosis of cutaneous melanoma.
|
Academic Article
|
Sentinel lymph node biopsy for melanoma: critical assessment at its twentieth anniversary.
|
Academic Article
|
Cutaneous melanoma: a model to study cancer metastasis.
|
Academic Article
|
Factors predictive of the status of sentinel lymph nodes in melanoma patients from a large multicenter database.
|
Academic Article
|
Lysophosphatidic acid induces lymphangiogenesis and IL-8 production in vitro in human lymphatic endothelial cells.
|
Academic Article
|
The challenge of defining guidelines for sentinel lymph node biopsy in patients with thin primary cutaneous melanomas.
|
Academic Article
|
Whole-genome sequencing identifies a recurrent functional synonymous mutation in melanoma.
|
Academic Article
|
Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients.
|
Academic Article
|
Improved staging of node-negative patients with intermediate to thick melanomas (>1 mm) with the use of lymphatic mapping and sentinel lymph node biopsy.
|
Academic Article
|
Presence of the human leukocyte antigen class II gene DRB1*1101 predicts interferon gamma levels and disease recurrence in melanoma patients.
|
Academic Article
|
Revised American Joint Committee on Cancer staging criteria accurately predict sentinel lymph node positivity in clinically node-negative melanoma patients.
|
Academic Article
|
Lessons learned from the Sunbelt Melanoma Trial.
|
Academic Article
|
Management of early-stage cutaneous melanoma.
|
Academic Article
|
Multivariate analysis of prognostic factors among 2,313 patients with stage III melanoma: comparison of nodal micrometastases versus macrometastases.
|
Academic Article
|
Outcomes in pediatric melanoma: comparing prepubertal to adolescent pediatric patients.
|
Academic Article
|
NRAS mutation status is an independent prognostic factor in metastatic melanoma.
|
Academic Article
|
Evidence-based clinical practice guidelines on the use of sentinel lymph node biopsy in melanoma.
|
Academic Article
|
Clinical value of the sentinel-node biopsy in primary cutaneous melanoma.
|
Academic Article
|
A highly recurrent RPS27 5'UTR mutation in melanoma.
|
Academic Article
|
Biology of advanced uveal melanoma and next steps for clinical therapeutics.
|
Academic Article
|
Beyond BRAF(V600): clinical mutation panel testing by next-generation sequencing in advanced melanoma.
|
Academic Article
|
Complete loss of PTEN protein expression correlates with shorter time to brain metastasis and survival in stage IIIB/C melanoma patients with BRAFV600 mutations.
|
Academic Article
|
The relationship between blood IL-12p40 level and melanoma progression.
|
Academic Article
|
Future perspectives in melanoma research: meeting report from the "Melanoma Bridge", Napoli, December 5th-8th 2013.
|
Academic Article
|
Teens and indoor tanning: time to act on the US Food and Drug Administration's black-box warning.
|
Academic Article
|
Ligand-directed targeting of lymphatic vessels uncovers mechanistic insights in melanoma metastasis.
|
Academic Article
|
Reduced adenosine-to-inosine miR-455-5p editing promotes melanoma growth and metastasis.
|
Academic Article
|
C-reactive protein as a marker of melanoma progression.
|
Academic Article
|
Is surviving enough? Coping and impact on activities of daily living among melanoma patients with lymphoedema.
|
Academic Article
|
Association of Common Genetic Polymorphisms with Melanoma Patient IL-12p40 Blood Levels, Risk, and Outcomes.
|
Academic Article
|
Utility of BRAF V600E Immunohistochemistry Expression Pattern as a Surrogate of BRAF Mutation Status in 154 Patients with Advanced Melanoma.
|
Academic Article
|
The long-term risk of upper-extremity lymphedema is two-fold higher in breast cancer patients than in melanoma patients.
|
Academic Article
|
Stemming the Rising Incidence of Melanoma: Calling Prevention to Action.
|
Academic Article
|
Principles of Melanoma Staging.
|
Academic Article
|
Loss of PTEN Promotes Resistance to T Cell-Mediated Immunotherapy.
|
Academic Article
|
Clinicopathological features and clinical outcomes associated with TP53 and BRAFNon-V600 mutations in cutaneous melanoma patients.
|
Academic Article
|
Melanoma prevention-avoiding indoor tanning and minimizing overexposure to the sun
|
Academic Article
|
Critical Assessment of Clinical Prognostic Tools in Melanoma
|
Academic Article
|
Clinical value of the sentinel-node biopsy in primary cutaneous melanoma
|
Academic Article
|
State of the science on prevention and screening to reduce melanoma incidence and mortality
|
Academic Article
|
Melanoma
|
Academic Article
|
Melanoma Expression Genes Identified through Genome-Wide Association Study of Breslow Tumor Thickness
|
Academic Article
|
4-nitroquinoline-1-oxide-induced mutagen sensitivity and risk of cutaneous melanoma
|
Academic Article
|
Cutaneous melanoma
|
Academic Article
|
Elevated serum leptin levels are associated with an increased risk of sentinel lymph node metastasis in cutaneous melanoma
|
Academic Article
|
Distinct clinical patterns and immune infiltrates are observed at time of progression on targeted therapy versus immune checkpoint blockade for melanoma
|
Academic Article
|
Biology of advanced uveal melanoma and next steps for clinical therapeutics
|
Academic Article
|
Is surviving enough? Coping and impact on activities of daily living among melanoma patients with lymphoedema
|
Academic Article
|
Integrated molecular and clinical analysis of AKT activation in metastatic melanoma
|
Academic Article
|
Inflammatory marker testing identifies CD74 expression in melanoma tumor cells, and its expression associates with favorable survival for stage III melanoma
|
Academic Article
|
The long-term risk of upper-extremity lymphedema is two-fold higher in breast cancer patients than in melanoma patients
|
Academic Article
|
Correlates of Sun Protection and Sunburn in Children of Melanoma Survivors
|
Academic Article
|
Melanoma survivorship management
|
Academic Article
|
Association of Vitamin D levels with outcome in patients with melanoma after adjustment for C-reactive protein
|
Academic Article
|
Future perspectives in melanoma research
|
Academic Article
|
Association of Common Genetic Polymorphisms with Melanoma Patient IL-12p40 Blood Levels, Risk, and Outcomes
|
Academic Article
|
Clinicopathological features and clinical outcomes associated with TP53 and BRAFN on- V 600 mutations in cutaneous melanoma patients
|
Academic Article
|
Melanoma Expression Genes Identified through Genome-Wide Association Study of?Breslow Tumor Thickness.
|
Academic Article
|
Association of Vitamin D Levels With Outcome in Patients With Melanoma After Adjustment For C-Reactive Protein.
|
Academic Article
|
Association between Body Mass Index, C-Reactive Protein Levels, and Melanoma Patient Outcomes.
|
Academic Article
|
Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients.
|
Academic Article
|
Association of body-mass index and outcomes in patients with metastatic melanoma treated with targeted therapy, immunotherapy, or chemotherapy: a retrospective, multicohort analysis.
|
Academic Article
|
Integrated Molecular and Clinical Analysis of AKT Activation in Metastatic Melanoma.
|
Academic Article
|
4-nitroquinoline-1-oxide-induced mutagen sensitivity and risk of cutaneous melanoma: a case-control analysis.
|
Academic Article
|
Inflammatory Marker Testing Identifies CD74 Expression in Melanoma Tumor Cells, and Its Expression Associates with Favorable Survival for Stage III Melanoma.
|
Academic Article
|
Final Results of the Sunbelt Melanoma Trial: A Multi-Institutional Prospective Randomized Phase III Study Evaluating the Role of Adjuvant High-Dose Interferon Alfa-2b and Completion Lymph Node Dissection for Patients Staged by Sentinel Lymph Node Biopsy.
|
Academic Article
|
The state of melanoma: challenges and opportunities.
|
Academic Article
|
State of the science on prevention and screening to reduce melanoma incidence and mortality: The time is now.
|
Academic Article
|
Analysis of Immune Signatures in Longitudinal Tumor Samples Yields Insight into Biomarkers of Response and Mechanisms of Resistance to Immune Checkpoint Blockade.
|
Academic Article
|
Distinct clinical patterns and immune infiltrates are observed at time of progression on targeted therapy versus immune checkpoint blockade for melanoma.
|
Academic Article
|
Correlates of Sun Protection and Sunburn in Children of Melanoma Survivors.
|
Academic Article
|
Melanoma.
|
Academic Article
|
Elevated Serum Leptin Levels are Associated With an Increased Risk of Sentinel Lymph Node Metastasis in Cutaneous Melanoma.
|
Academic Article
|
Critical Assessment of Clinical Prognostic Tools in Melanoma.
|
Academic Article
|
Sex Differences in Age at Primary Melanoma Diagnosis in a Population-Based Analysis (US?Surveillance, Epidemiology, and End Results, 2005-2011).
|
Academic Article
|
Melanoma Prevention-Avoiding Indoor Tanning and Minimizing Overexposure to the Sun.
|
Academic Article
|
Tumor Thickness and Mitotic Rate Robustly Predict Melanoma-Specific Survival in Patients with Primary Vulvar Melanoma: A Retrospective Review of 100 Cases.
|
Academic Article
|
Novel algorithmic approach predicts tumor mutation load and correlates with immunotherapy clinical outcomes using a defined gene mutation set.
|
Academic Article
|
Skin Cancer: Have melanoma and skin cancer finally met their match?
|
Academic Article
|
Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma.
|
Academic Article
|
Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma.
|
Academic Article
|
Genomic and immune heterogeneity are associated with differential responses to therapy in melanoma.
|
Academic Article
|
Melanoma staging: Evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual.
|
Academic Article
|
Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma.
|
Academic Article
|
Clinical impact of ulceration width, lymphovascular invasion, microscopic satellitosis, perineural invasion, and mitotic rate in patients undergoing sentinel lymph node biopsy for cutaneous melanoma: a retrospective observational study at a comprehensive cancer center.
|
Academic Article
|
Variability in Predictions from Online Tools: A Demonstration Using Internet-Based Melanoma Predictors.
|
Academic Article
|
Prospective Analysis of Adoptive TIL Therapy in Patients with Metastatic Melanoma: Response, Impact of Anti-CTLA4, and Biomarkers to Predict Clinical Outcome.
|
Academic Article
|
Melanoma Staging: American Joint Committee on Cancer (AJCC) 8th Edition and Beyond.
|
Academic Article
|
Neoadjuvant plus adjuvant dabrafenib and trametinib versus standard of care in patients with high-risk, surgically resectable melanoma: a single-centre, open-label, randomised, phase 2 trial.
|
Academic Article
|
The Great Debate at "Melanoma Bridge", Napoli, December 2nd, 2017.
|
Academic Article
|
Case Report of Myeloid Sarcoma Masquerading as In-Transit Metastasis at a Previous Melanoma Site: Avoiding a Diagnostic Pitfall.
|
Academic Article
|
The eighth edition American Joint Committee on Cancer (AJCC) melanoma staging system: implications for melanoma treatment and care.
|
Academic Article
|
Chemoprevention agents for melanoma: A path forward into phase 3 clinical trials.
|
Academic Article
|
A model for predicting low probability of nonsentinel lymph node positivity in melanoma patients with a single positive sentinel lymph node.
|
Academic Article
|
Guidelines of care for the management of primary cutaneous melanoma.
|
Academic Article
|
Correction to: Melanoma Staging: American Joint Committee on Cancer (AJCC) 8th Edition and Beyond.
|
Academic Article
|
ErbB3 Targeting Enhances the Effects of MEK Inhibitor in Wild-Type BRAF/NRAS Melanoma.
|
Academic Article
|
Role of Elevated PHIP Copy Number as a Prognostic and Progression Marker for Cutaneous Melanoma.
|
Academic Article
|
Pathological assessment of resection specimens after neoadjuvant therapy for metastatic melanoma.
|
Academic Article
|
Lifestyle Modifications and Policy Implications for Primary and Secondary Cancer Prevention: Diet, Exercise, Sun Safety, and Alcohol Reduction.
|
Academic Article
|
Staging of Cutaneous Melanoma: Is There Room for Further Improvement?
|
Academic Article
|
Telementoring and smartphone-based answering systems to optimize dermatology resident dermoscopy education.
|
Academic Article
|
Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma.
|
Academic Article
|
Author Correction: Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma.
|
Academic Article
|
Publisher Correction: Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma.
|
Academic Article
|
Distinct Clinicopathological and Prognostic Features of Thin Nodular Primary Melanomas: An International Study from 17 Centers.
|
Academic Article
|
Completion Node Dissection for Sentinel Node-Positive Melanoma: Can a Systematic Review Bring One Discussion to a Close While Leaving the Broader Conversation Still Open?
|
Academic Article
|
Molecular Profiling Reveals Unique Immune and Metabolic Features of Melanoma Brain Metastases.
|
Academic Article
|
Embracing changes to the American Joint Committee on Cancer 8th edition melanoma staging system.
|
Academic Article
|
Biological Validation of RNA Sequencing Data from Formalin-Fixed Paraffin-Embedded Primary Melanomas.
|
Concept
|
Melanoma-Specific Antigens
|
Academic Article
|
Role of Immune Response, Inflammation, and Tumor Immune Response-Related Cytokines/Chemokines in Melanoma Progression.
|
Academic Article
|
Neoadjuvant systemic therapy in melanoma: recommendations of the International Neoadjuvant Melanoma Consortium.
|
Academic Article
|
Isolated Imunohistochemistry-positive Cells Without Morphologic Characteristics of Melanoma Should Not Result in Designation as a Positive Sentinel Lymph Node According to the AJCC 8th Edition Staging System.
|
Academic Article
|
Prognostic model for patient survival in primary anorectal mucosal melanoma: stage at presentation determines relevance of histopathologic features.
|
Academic Article
|
Enhancing Case Capture, Quality, and Completeness of Primary Melanoma Pathology Records via Natural Language Processing.
|
Academic Article
|
Correlation of Tumor Burden in Sentinel Lymph Nodes with Tumor Burden in Nonsentinel Lymph Nodes and Survival in Cutaneous Melanoma.
|
Academic Article
|
Functional annotation of melanoma risk loci identifies novel susceptibility genes.
|
Academic Article
|
Quantitative associations between health insurance and stage of melanoma at diagnosis among nonelderly adults in the United States.
|
Academic Article
|
Melanoma pathology reporting and staging.
|
Academic Article
|
KEYNOTE-716: Phase III study of adjuvant pembrolizumab versus placebo in resected high-risk stage II melanoma.
|
Academic Article
|
FOXD3 Regulates VISTA Expression in Melanoma.
|
Academic Article
|
B cells and tertiary lymphoid structures promote immunotherapy response.
|
Academic Article
|
Cumulative Incidence and Predictors of CNS Metastasis for Patients With American Joint Committee on Cancer 8th Edition Stage III Melanoma.
|
Academic Article
|
Circulating Tumor Cells and Early Relapse in Node-positive Melanoma.
|
Academic Article
|
Clinicopathological Features, Staging, and Current Approaches to Treatment in High-Risk Resectable Melanoma.
|
Academic Article
|
The Great Debate at "Melanoma Bridge", Naples, December 7th, 2019.
|
Academic Article
|
Improved Risk Prediction Calculator for Sentinel Node Positivity in Patients With Melanoma: The Melanoma Institute Australia Nomogram.
|
Academic Article
|
Prognostic Gene Expression Profiling in Cutaneous Melanoma: Identifying the Knowledge Gaps and Assessing the Clinical Benefit.
|
Academic Article
|
Histopathological features of complete pathological response predict recurrence-free survival following neoadjuvant targeted therapy for metastatic melanoma.
|
Academic Article
|
Surgical decision-making and prioritization for cancer patients at the onset of the COVID-19 pandemic: A multidisciplinary approach.
|
Academic Article
|
Molecular and immunological associations of elevated serum lactate dehydrogenase in metastatic melanoma patients: A fresh look at an old biomarker.
|
Academic Article
|
The State of Melanoma: Emergent Challenges and Opportunities.
|
Academic Article
|
A multicentre study of naevus-associated melanoma vs. de novo melanoma, tumour thickness and body site differences.
|
Academic Article
|
Updates in the evidence-based management of cutaneous melanoma.
|
Academic Article
|
Sentinel node biopsy for primary cutaneous melanoma.
|
Academic Article
|
Discordance in Diagnosis of Melanocytic Lesions and Its Impact on Clinical Management.
|
Academic Article
|
Active surveillance of patients who have melanoma with a positive sentinel node in an era of effective adjuvant therapy: Early lessons learned ? and still learning.
|
Academic Article
|
The "Great Debate" at Melanoma Bridge 2020: December, 5th, 2020.
|
Academic Article
|
Nodal Recurrence is a Primary Driver of Early Relapse for Patients with Sentinel Lymph Node-Positive Melanoma in the Modern Therapeutic Era.
|
Academic Article
|
High sensitivity sanger sequencing detection of BRAF mutations in metastatic melanoma FFPE tissue specimens.
|
Academic Article
|
Gut microbiota signatures are associated with toxicity to combined CTLA-4 and PD-1 blockade.
|
Academic Article
|
Identification of MicroRNA-mRNA Networks in Melanoma and Their Association with PD-1 Checkpoint Blockade Outcomes.
|
Academic Article
|
Short-term treatment with multi-drug regimens combining BRAF/MEK-targeted therapy and immunotherapy results in durable responses in Braf-mutated melanoma.
|
Academic Article
|
Utilization and evolving prescribing practice of opioid and non-opioid analgesics in patients undergoing lymphadenectomy for cutaneous malignancy.
|
Academic Article
|
Evaluation of Plasma IL-6 in Patients with Melanoma as a Prognostic and Checkpoint Immunotherapy Predictive Biomarker.
|
Academic Article
|
Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response.
|
Academic Article
|
Neoadjuvant Systemic Therapy (NAST) in Patients with Melanoma: Surgical Considerations by the International Neoadjuvant Melanoma Consortium (INMC).
|
Academic Article
|
Outcomes After Sphincter-Sparing Local Therapy for Anorectal Melanoma: 1989 to 2020.
|
Academic Article
|
Correction to: Neoadjuvant Systemic Therapy (NAST) in Patients with Melanoma: Surgical Considerations by the International Neoadjuvant Melanoma Consortium (INMC).
|
Academic Article
|
An Evidence-Based Staging System for Mucosal Melanoma: A Proposal.
|
Academic Article
|
The "Great Debate" at Melanoma Bridge 2021, December 2nd-4th, 2021.
|
Academic Article
|
Clinically Significant Risk Thresholds in the Management of Primary Cutaneous Melanoma: A Survey of Melanoma Experts.
|
Academic Article
|
Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy.
|
Academic Article
|
Multi-modal molecular programs regulate melanoma cell state.
|
Academic Article
|
Pembrolizumab versus placebo as adjuvant therapy in resected stage IIB or IIC melanoma (KEYNOTE-716): distant metastasis-free survival results of a multicentre, double-blind, randomised, phase 3 trial.
|
Academic Article
|
Neoadjuvant relatlimab and nivolumab in resectable melanoma.
|
Academic Article
|
Obesity Is Associated with Altered Tumor Metabolism in Metastatic Melanoma.
|
Academic Article
|
Prognostic impact of Breslow thickness in acral melanoma: A retrospective analysis.
|
Academic Article
|
Therapeutic Value of Sentinel Lymph Node Biopsy in Patients With Melanoma: A Randomized Clinical Trial.
|
Academic Article
|
Changes in outcomes and factors associated with survival in melanoma patients with brain metastases.
|
Academic Article
|
Author Correction: Neoadjuvant relatlimab and nivolumab in resectable melanoma.
|
Academic Article
|
Melanoma metastatic to the adrenal gland: An update on the role of adrenalectomy in multidisciplinary management.
|
Academic Article
|
The "Great Debate" at Melanoma Bridge 2022, Naples, December 1st-3rd, 2022.
|
Academic Article
|
Regarding: Predicting Regional Lymph Node Recurrence in The Modern Age of Tumor-Positive Sentinel Node Melanoma.
|
Academic Article
|
Mitotic rate in primary cutaneous melanoma: Cell division matters.
|
Academic Article
|
Perspectives in Melanoma: meeting report from the Melanoma Bridge (December 1st-3rd, 2022-Naples, Italy).
|
Academic Article
|
Presence of Circulating Tumor Cells Predates Imaging Detection of Relapse in Patients with Stage III Melanoma.
|
Academic Article
|
Top Melanoma Articles from 2021 to Inform Your Cancer Practice.
|
Academic Article
|
Cutaneous melanoma.
|
Academic Article
|
Gut Microbiome in Patients With Early-Stage and Late-Stage Melanoma.
|
Academic Article
|
Proceedings from the Melanoma Research Foundation Mucosal Melanoma Meeting (December 16, 2022, New York, USA).
|
Academic Article
|
Predicting Recurrence-Free and Overall Survival for Patients With Stage II Melanoma: The MIA Calculator.
|
Academic Article
|
Health Economic Consequences Associated With COVID-19-Related Delay in Melanoma Diagnosis in Europe.
|